Andrew Chang on AI, Marketing and Responsible Growth at UChicago Medicine
Becker’s Healthcare PodcastSummary
Hospital and health system leaders face a complex strategic agenda, with challenges including market consolidation, reimbursement pressures, and workforce dynamics. The 14th annual CEO CFO Roundtable, hosted by Ecker, aims to equip over 1,500 executives with insights to navigate these issues. The event, scheduled for November 2-5 in Chicago, will feature nearly 400 speakers who will help leaders refine their priorities for the upcoming year.
Andrew Chang, Chief Marketing Officer at UChicago Medicine, highlights the organization's significant achievements over the past year, including a $1.1 billion community benefit investment and the appointment of new leadership in key positions. UChicago Medicine is also focusing on innovative marketing strategies that demonstrate a positive return on investment, emphasizing patient engagement and care gap closure through targeted communications.
Looking ahead, UChicago Medicine is leveraging artificial intelligence to enhance patient interactions, including the implementation of a chatbot for appointment management. Chang stresses the importance of responsible growth and resource allocation, particularly in the context of the upcoming Cancer Pavilion, which aims to transform cancer care in the Chicago area. He draws inspiration from leaders like Mr. Rogers, emphasizing the impact that individuals can have in advocating for community health and wellness.
Show Notes
In this episode, Andrew Chang, Chief Marketing Officer, UChicago Medicine, discusses using AI and marketing technology to improve patient access, measure ROI, support responsible growth and transform the healthcare experience. He also shares UChicago Medicine's plans for its new cancer center and its broader vision for the future of care.
More from Becker’s Healthcare Podcast
This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Tinu Tadese, MD, System Chief Medical Informatics Officer, Boston Medical Center, who discusses reducing data fragmentation, preserving clinical context across care transitions and turning patient data into actionable insights
In this episode, John D’Angelo, MD, President and CEO of Northwell Health, discusses a fundamentally different approach to treating rheumatoid arthritis (RA): bioelectronic medicine, which uses the body’s own nervous system to help regulate the inflammation that drives the disease. Delivered by a small implanted medical device that stimulates the vagus nerve, the FDA-approved therapy offers an alternative to costly medications that can also cause significant side effects or fail to provide adequate relief.
In this episode, Ryan Mezinger, Senior Vice President and Chief Pharmacy Officer at MetroHealth, and Dr. Amit Gir, CEO and Co-Founder of Phox Health, discuss how MetroHealth's pharmacy delivery model is improving medication access, adherence, patient satisfaction, and care continuity while strengthening chain of custody and pharmacy operations.
In this episode, Dr. Kyle W. Trecartin, Chief Medical Officer, Beth Israel Deaconess Hospital - Plymouth, discusses improving patient throughput, strengthening quality and safety through a just culture, and expanding access to care in the community.
In this episode, Erica Rowe Urquhart, MD, PhD, Orthopedic Surgeon, Author, Healthcare Thought Leader, discusses how reimbursement pressures shape independent medical practices, why physicians must understand healthcare finance, and the leadership skills needed to sustain quality patient care.